(Q41350146)
Statements
1 reference
Strategic proposals for avoiding toxic interactions with drugs for clinical use during development and after marketing of a new drug: pharmacokinetic consideration (English)
1 reference
Sugiyama Y
1 reference
Iwatsubo T
1 reference
Ueda K
1 reference
Ito K
1 reference
1 December 1996
1 reference
1 reference
21
1 reference
5
1 reference
309-316
1 reference
Identifiers
1 reference
1 reference